In gliomas, a higher proportion of CD133+ tumor cells survived radiotherapy than CD133- cells and showed post-radiotherapy enrichment, and these CD133+ cells are also thought to be the source of tumor recurrence after radiotherapy 16. The gene discussed is PROM1; the disease is neoplasm.